vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · IEX Real-Time Price · USD
18.78
-1.46 (-7.21%)
Jun 18, 2024, 4:00 PM EDT - Market closed

vTv Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019 2018 - 2013
Revenue
02.024.016.412.76
Upgrade
Revenue Growth (YoY)
--49.61%-37.56%132.05%-77.77%
Upgrade
Gross Profit
02.024.016.412.76
Upgrade
Selling, General & Admin
11.9112.212.347.258.54
Upgrade
Research & Development
13.612.3613.3211.0215.12
Upgrade
Other Operating Expenses
-0.57-0.95-1.610.27-0.83
Upgrade
Operating Expenses
24.9323.6124.0618.5422.83
Upgrade
Operating Income
-24.93-21.59-20.05-12.12-20.07
Upgrade
Interest Expense / Income
0.010.020.010.691.83
Upgrade
Other Expense / Income
-4.69-2.65-7.19-4.32-8.95
Upgrade
Pretax Income
-20.25-18.96-12.87-8.5-12.94
Upgrade
Income Tax
00.20.1200.1
Upgrade
Net Income
-20.25-19.16-12.99-8.5-13.04
Upgrade
Preferred Dividends
00004.87
Upgrade
Net Income Common
-20.25-19.16-12.99-8.5-17.91
Upgrade
Shares Outstanding (Basic)
33221
Upgrade
Shares Change
-16.15%21.87%23.33%47.01%
Upgrade
EPS (Basic)
-9.71-9.98-8.29-7.20-23.60
Upgrade
EPS (Diluted)
-9.71-9.98-8.29-7.20-23.60
Upgrade
Free Cash Flow
-19.08-16.04-19.31-18-22.78
Upgrade
Free Cash Flow Per Share
-7.30-6.14-8.58-9.74-15.21
Upgrade
Gross Margin
-100.00%100.00%100.00%100.00%
Upgrade
Operating Margin
--1070.07%-500.70%-188.99%-725.94%
Upgrade
Profit Margin
--949.65%-324.27%-132.51%-648.08%
Upgrade
Free Cash Flow Margin
--795.00%-482.10%-280.64%-824.02%
Upgrade
EBITDA
-20.15-18.86-12.77-7.71-11.08
Upgrade
EBITDA Margin
--934.44%-318.88%-120.25%-400.80%
Upgrade
Depreciation & Amortization
0.090.090.090.090.04
Upgrade
EBIT
-20.24-18.95-12.86-7.81-11.12
Upgrade
EBIT Margin
--939.00%-321.10%-121.72%-402.21%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).